Prospective randomized studies are needed to define the role of axillary lymph node dissection in primary breast cancer [3] (multiple letters)

Journal of Clinical Oncology

Volumn 15, Issue 8, 1997, Pages 3023-3024

  Costa, S D ^a   Von Minckwitz, G ^a   Gauwerky, J F H ^a   Kaufmann, M ^a   Diel, I J ^a   affty, D G ^a  

^a GOETHE UNIVERSITY MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ADJUVANT THERAPY; AXILLARY LYMPH NODE; BREAST CANCER; DECISION MAKING; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LETTER; LYMPH NODE DISSECTION; PRIORITY JOURNAL; PROGNOSIS; TREATMENT PLANNING;

EID: 0030872768     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.8.3023     Document Type: Letter

References (0)